Brief: ERYTECH Provides Business And Financial Update For Third Quarter
Nov 21 (Reuters) - Erytech Pharma SA ERYP.PA :
* ERYTECH PROVIDES BUSINESS AND FINANCIAL UPDATE FOR THE
THIRD
QUARTER OF 2022
* ERYTECH PHARMA SA - AS OF SEPTEMBER 30, 2022, ERYTECH HAD
CASH
AND CASH EQUIVALENTS TOTALING EUR 47.3 MILLION
* ERYTECH PHARMA SA - DEEP RESTRUCTURING IMPLEMENTED; TEAM
SIZE
REDUCED BY APPROXIMATELY 75% SINCE START OF YEAR
Source text for Eikon: ID:nGNX2RxC8L
Further company coverage: ERYP.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phaxiam Therapeutics SA
See all newsBrief: Phaxiam Therapeutics Announces The Suspension Of Trading In Its Shares Until Delisting
Brief: Phaxiam Therapeutics Announces Judicial Liquidation And Delisting
Brief: Phaxiam Therapeutics Says Postponement Of The Offer Review Hearing
Brief: Phaxiam Therapeutics Announces Launch Of Process To Find Buyers In Context Of Its Receivership Procedure
Brief: Phaxiam Therapeutics Says Commercial Court Of Lyon To Open Judicial Receivership Procedure